When we combined the LRRC8A siRNA with chemotherapeutics, our assays again showed a strong trend for additivity in the toxic effects of both treatments, and were far superior to the chemotherapeutics alone.
← all excerpts
Downregulation of Leucine-Rich Repeat-Containing 8A Limits Proliferation and Increases Sensitivity of Glioblastoma to Temozolomide and Carmustine.
1
—
—